1HELD C, HJEMDAHL P, HAKAN W N,et al. Inflammatory and hemostatic markers in relation to cardiovascular prognosis in patients with stable angina pectoris, results from the APSIS study. The angina prognosis study in Stokholm [J]. Atherosclerosis ,2000,148:179- 188.
2LOUKAS M,DABROWSKI M, WANGNER T, et al.Fibrinogen and smooth muscle cell detection in atherosclerotic plaque from stable and unstable angina an immunohistochemical study[J]. Med Sci Monist ,2002,8:144-148.
3DEVARAJ S, XU D Y, JIALAL I, C-reaction protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis[J]. Circulation, 2003, 107: 398-404.
4PATETSIOS P, SONG M, SHUTZE W P. Identification of uric and xanthine oxidase in atherosclerotic plaque[J]. Am J Cardiol ,2001,88:188-191.
5HEITZER T, SCHLIINZIG T, KROHN K, et al.Endothelial disfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease[J]. Circulation, 2002,104:2673 - 2678.
6Zahi A, Fayad Z A, Fuster V, et al. Computed tomography and magnetic resonance imaging for noninvasivc coronary angiography and plaque imaging: current and potential future concepts. Circulation, 2002, 106:2026-2034.
7Ridker P M, Cushman M, Stampfer M J, et al. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation, 1998, 97:425-428.
8DeCaterina R, Basta G, Lazzerini G, et al. Soluble vascular cell adhesion molecule-1 as a biohumoral correlate of atherosclerosis. Artherioscler Thromb Vasc Biol,1997,17 : 2646- 2654.
9Ridker P M, Hennekens C H, Roitman-Johson B, et al. Plasma concentration of soluble intercellular adhesion molecule 1 and risk of future myocardial infarction in apparently healthy men. Lancet, 1998,351:88-92.
10Ridker P M, Burning J E, Rifal N. Soluble P-selection and the risk of future cardiovascular events. Circulation, 2001,103:491 -495.
